BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 32723142)

  • 1. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
    Abd Ellah NH; Gad SF; Muhammad K; E Batiha G; Hetta HF
    Nanomedicine (Lond); 2020 Sep; 15(21):2085-2102. PubMed ID: 32723142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The race against COVID-19.
    Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    Hosoki K; Chakraborty A; Sur S
    J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
    Li H; Liu Z; Ge J
    J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
    Gupta SP
    Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-2019: update on epidemiology, disease spread and management.
    Sahu KK; Mishra AK; Lal A
    Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
    Fadaka AO; Sibuyi NRS; Adewale OB; Bakare OO; Akanbi MO; Klein A; Madiehe AM; Meyer M
    J Int Med Res; 2020 Aug; 48(8):300060520949077. PubMed ID: 32842818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: Progress in diagnostics, therapy and vaccination.
    Liu X; Liu C; Liu G; Luo W; Xia N
    Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Banerjee AK; Arora N
    Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19: Main therapeutic options.
    Hachfi W; Ben Lasfar N
    Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
    [No Abstract]   [Full Text] [Related]  

  • 12. The COVID-19 pandemic.
    Salahuddin N
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S4-S6. PubMed ID: 32515365
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
    Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
    Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
    Khalaf K; Papp N; Chou JT; Hana D; Mackiewicz A; Kaczmarek M
    Front Immunol; 2020; 11():570927. PubMed ID: 33123144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.
    Amawi H; Abu Deiab GI; A Aljabali AA; Dua K; Tambuwala MM
    Ther Deliv; 2020 Apr; 11(4):245-268. PubMed ID: 32397911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacological treatments for SARS-COV-2: A narrative review.
    Nittari G; Pallotta G; Amenta F; Tayebati SK
    Eur J Pharmacol; 2020 Sep; 882():173328. PubMed ID: 32603692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Urgent Need for "Common Cold Units" to Study COVID-19.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1152-1153. PubMed ID: 32274988
    [No Abstract]   [Full Text] [Related]  

  • 20. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.